Autologous, Adipose-derived Mesenchymal Stem Cell Therapy(Vinmec Research Institute Of Stem Cell And Gene Technology)

N/A

Report date: 2024/12/11 20:00:45

Base Information

Drug NameAutologous, Adipose-derived Mesenchymal Stem Cell Therapy(Vinmec Research Institute Of Stem Cell And Gene Technology)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Source of cells > Adipose-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsSexual Dysfunction, Physiological

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryVietnam

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesVinmec Research Institute Of Stem Cell And Gene Technology

China Registration ClassN/A

Develop Information

Active CompaniesVinmec Research Institute Of Stem Cell And Gene Technology

Inactive CompaniesN/A

Active IndicationsSexual Dysfunction, Physiological

Inactive IndicationsN/A

Other Information

ATC CodeN/A